Nash RA, Caldecott KW, Barnes DE, Lindahl T (April 1997). "XRCC1 protein interacts with one of two distinct forms of DNA ligase III". Biochemistry36 (17): 5207–11. PMID9136882. doi:10.1021/bi962281m.
Parsons JL, Dianova II, Finch D, Tait PS, Ström CE, Helleday T, Dianov GL (July 2010). "XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair". DNA Repair (Amst.)9 (7): 835–41. PMID20471329. doi:10.1016/j.dnarep.2010.04.008.
Moser J, Kool H, Giakzidis I, Caldecott K, Mullenders LH, Fousteri MI (July 2007). "Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner". Mol. Cell27 (2): 311–23. PMID17643379. doi:10.1016/j.molcel.2007.06.014.
Girard PM, Kysela B, Härer CJ, Doherty AJ, Jeggo PA (October 2004). "Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms". Hum. Mol. Genet.13 (20): 2369–76. PMID15333585. doi:10.1093/hmg/ddh274.
O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P (December 2001). "DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency". Mol. Cell8 (6): 1175–85. PMID11779494. doi:10.1016/S1097-2765(01)00408-7.
Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA (July 1999). "Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient". Curr. Biol.9 (13): 699–702. PMID10395545. doi:10.1016/S0960-9822(99)80311-X.
Barnes DE, Tomkinson AE, Lehmann AR, Webster AD, Lindahl T (May 1992). "Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents". Cell69 (3): 495–503. PMID1581963. doi:10.1016/0092-8674(92)90450-Q.
Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, Takahashi T, Nagatomo H, Sekijima Y, Kawachi I, Takiyama Y, Nishizawa M, Fukuhara N, Saito K, Sugano S, Tsuji S (October 2001). "Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene". Nat. Genet.29 (2): 184–8. PMID11586299. doi:10.1038/ng1001-184.
Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T, Mendonça P, Costa M, Barros J, Yanagisawa T, Watanabe M, Ikeda Y, Aoki M, Nagata T, Coutinho P, Sequeiros J, Koenig M (October 2001). "The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin". Nat. Genet.29 (2): 189–93. PMID11586300. doi:10.1038/ng1001-189.
Nash RA, Caldecott KW, Barnes DE, Lindahl T (April 1997). "XRCC1 protein interacts with one of two distinct forms of DNA ligase III". Biochemistry36 (17): 5207–11. PMID9136882. doi:10.1021/bi962281m.
Parsons JL, Dianova II, Finch D, Tait PS, Ström CE, Helleday T, Dianov GL (July 2010). "XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair". DNA Repair (Amst.)9 (7): 835–41. PMID20471329. doi:10.1016/j.dnarep.2010.04.008.
Moser J, Kool H, Giakzidis I, Caldecott K, Mullenders LH, Fousteri MI (July 2007). "Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner". Mol. Cell27 (2): 311–23. PMID17643379. doi:10.1016/j.molcel.2007.06.014.
Girard PM, Kysela B, Härer CJ, Doherty AJ, Jeggo PA (October 2004). "Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms". Hum. Mol. Genet.13 (20): 2369–76. PMID15333585. doi:10.1093/hmg/ddh274.
O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P (December 2001). "DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency". Mol. Cell8 (6): 1175–85. PMID11779494. doi:10.1016/S1097-2765(01)00408-7.
Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA (July 1999). "Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient". Curr. Biol.9 (13): 699–702. PMID10395545. doi:10.1016/S0960-9822(99)80311-X.
Barnes DE, Tomkinson AE, Lehmann AR, Webster AD, Lindahl T (May 1992). "Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents". Cell69 (3): 495–503. PMID1581963. doi:10.1016/0092-8674(92)90450-Q.
Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, Takahashi T, Nagatomo H, Sekijima Y, Kawachi I, Takiyama Y, Nishizawa M, Fukuhara N, Saito K, Sugano S, Tsuji S (October 2001). "Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene". Nat. Genet.29 (2): 184–8. PMID11586299. doi:10.1038/ng1001-184.
Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, Gibson T, Mendonça P, Costa M, Barros J, Yanagisawa T, Watanabe M, Ikeda Y, Aoki M, Nagata T, Coutinho P, Sequeiros J, Koenig M (October 2001). "The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin". Nat. Genet.29 (2): 189–93. PMID11586300. doi:10.1038/ng1001-189.